Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Condition:   Asthma
Interventions:   Drug: Fp MDPI;   Drug: FS MDPI;   Drug: Placebo
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified November 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.